Removing rhabdovirus (RV) from cell culture process to enable RV-negative production of rAAV

Authors

• Luhong He, Eli Lilly and Company, USAFollow
• Christopher Hatfield, Upstream Process Development, Lilly Research Liberatory, Eli Lilly and Company
• Hunter Balduf, Upstream Process Development, Lilly Research Liberatory, Eli Lilly and Company
• Michael Lloyd, Upstream Process Development, Lilly Research Liberatory, Eli Lilly and Company

Conference Dates

April 27 - May 2, 2025

Abstract

Please click Additional Files below to see the full abstract

Recommended Citation

Luhong He, Christopher Hatfield, Hunter Balduf, and Michael Lloyd, "Removing rhabdovirus (RV) from cell culture process to enable RV-negative production of rAAV" in "Cell Culture Engineering XIX", A Khetan, BMS; Marcella Yu, Gilead; Mike Betenbaugh, Johns Hopkins University Eds, ECI Symposium Series, (2025). https://dc.engconfintl.org/cell_culture_engineering_xix/215